"Gideon Koren" from_date:2012

Lead, CanFASD Research NetworkJury questions and answers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .167Meconium testing for FASD: Promises and challenges . . . . . . . . . . . . . . . . . . . . . . . . . . .170 Gideon Koren, Director, Motherisk Program, The Hospital for Sick Children; Professor of Pediatrics, Pharmacology, Pharmacy, and Medical

. Michael’s Hospital, Toronto Adjunct Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute Assistant Professor, Health Policy, Management and Evaluation, University of Toronto Gideon Koren, MD Director, Motherisk Program, The Hospital for Sick Children, Toronto Senior Scientist, Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto Professor, Faculty of Medicine

arrhythmias. The sessions of the Symposium focusing on the functional roles of the cardiac K channel in health and disease, as well as K channels as therapeutic targets, were contributed by Ye Chen-Izu, Gideon Koren, James Weiss, David Paterson, David Christini, Dobromir Dobrev, Jordi Heijman, Thomas O'Hara, Crystal Ripplinger, Zhilin Qu, Jamie Vandenberg, Colleen Clancy, Isabelle Deschenes, Leighton Izu

is considered for use throughout Europe.ConclusionThis unreported trial was sponsored by Duchesnay Inc. in collaboration with Premier Research Group plc. The study PIs are Dr. Gideon Koren of the Hospital for Sick Children in Toronto, Canada and Dr. Gary Hankins of the University of Texas in the US. As of 26 June 2018, this trial is 87 days overdue to report. We hope the investigators will share the results

and Gynaecology in publishing two fraudulent papers which had the editor of the journal as an author on one and an assistant editor as an author on both. But more than 20 years later a report in the Toronto Starappears to show that amateur editing is flourishing as ever.The report in the Toronto Star describes how a review of more than 1400 papers by Gideon Koren, one of Canada’s most prolific scientific

)30999-3. PMID23470115. 26. ^ Cardonick E, Bhat A, Gilmandyar D, Somer R (2012). "Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature". Ann. Oncol. 23 (12): 3016–23. doi:10.1093/annonc/mds170. PMID22875836. 27. ^ a b Gideon Koren, Nathalie Carey, Robert Gagnon, et al. Cancer Chemotherapy and Pregnancy, "Journal

Recruitment Status : Completed First Posted : November 24, 2014 Last Update Posted : November 24, 2014 Sponsor: The Hospital for Sick Children Collaborator: Duchesnay Inc. Information provided by (Responsible Party): Gideon Koren, The Hospital for Sick Children * Study Details * Tabular View * No Results Posted * Disclaimer * How to Read a Study RecordStudy DescriptionGo to Top of Page Study using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02300155 Locations Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Sponsors and Collaborators The Hospital for Sick Children Duchesnay Inc. Investigators Principal Investigator: Gideon Koren

Recruitment Status : Completed First Posted : November 25, 2014 Last Update Posted : November 25, 2014 Sponsor: The Hospital for Sick Children Collaborator: Duchesnay Inc. Information provided by (Responsible Party): Gideon Koren, The Hospital for Sick Children * Study Details * Tabular View * No Results Posted * Disclaimer * How to Read a Study RecordStudy DescriptionGo to Top of Page Study to this study by its ClinicalTrials.gov identifier (NCT number): NCT02300948 Locations Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Sponsors and Collaborators The Hospital for Sick Children Duchesnay Inc. Investigators Principal Investigator: Gideon Koren, MD The Hospital for Sick Children, Toronto Canada More InformationGo